Te Ahumairangi Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.52M Buy
2,735
+135
+5% +$137K 0.42% 74
2025
Q4
$2.79M Sell
2,600
-520
-17% -$497K 0.5% 67
2025
Q3
$2.38M Buy
+3,120
New +$2.32M 0.4% 76

Other funds holding LLY

Te Ahumairangi Investment Management's LLY Position: Q1 2026 in Review

Te Ahumairangi Investment Management increased its Eli Lilly (LLY) stake by 5.2% in Q1 2026, buying an estimated $137K and bringing the position to 2,735 shares worth $2.52M. The position accounts for 0.42% of the portfolio, ranked #74.

Te Ahumairangi Investment Management first reported a position in LLY in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.79M in Q4 2025. 4,362 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Te Ahumairangi Investment Management held 2,735 shares of Eli Lilly worth $2.52M as of Q1 2026.
  • Te Ahumairangi Investment Management bought 135 Eli Lilly shares in Q1 2026, an estimated $137K.
  • Eli Lilly made up 0.42% of Te Ahumairangi Investment Management's portfolio in Q1 2026, its #74 holding.
  • Te Ahumairangi Investment Management first reported a position in Eli Lilly in Q3 2025 and has held it in 3 quarters since.
  • Te Ahumairangi Investment Management's Eli Lilly position peaked at $2.79M in Q4 2025.
  • 4,362 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Te Ahumairangi Investment Management's 13F filing for Q1 2026, filed 15 May 2026.